SILK ROAD MEDICAL INC (SILK) Stock Price, Quote, News and Summary
NASDAQ:SILK - Nasdaq - US82710M1009 - Common Stock
SILK Quote and Key Statistics
SILK ROAD MEDICAL INC
NASDAQ:SILK (9/16/2024, 8:00:02 PM)
After market: 27.49 0 (0%)27.49
-0.01 (-0.04%)
SILK Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -20.96% | ||
| ROE | -36.55% | ||
| Debt/Equity | 0.49 |
SILK Performance and Technical Analysis
SILK Ownership and Analysts
SILK Latest News and Analysis
Boston Scientific Announces Results for Third Quarter 2024
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.209 billion during the third quarter of 2024, growing 19.4 percent on a...
Boston Scientific Closes Acquisition of Silk Road Medical, Inc.
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Silk Road Medical, Inc. (Nasdaq: SILK), a medical...
Boston Scientific: Why This MedTech Giant Isn’t Slowing Down
Boston Scientific Co (NYSE: BSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPR, INFN, SILK on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, BALY, K on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, ALIM, INFN on Behalf of Shareholders
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
About SILK
Company Profile
Silk Road Medical, Inc. engages in the development and manufacturing of medical devices to treat neurovascular diseases. The company is headquartered in Sunnyvale, California and currently employs 474 full-time employees. The company went IPO on 2019-04-04. The firm has developed an approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Its product portfolio consists of five single-use components: ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent System, ENHANCE Transcarotid Peripheral Access Kit, ENROUTE 0.014'' Guidewire and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter. The company manufactures ENROUTE NPS and ENROUTE NPS PLUS, or its ENROUTE NPS products, at its facilities in Sunnyvale, California and Plymouth, Minnesota. These facilities provide an aggregate of over 35,000 square feet of space for its production and distribution operations.
Company Info
SILK ROAD MEDICAL INC
1213 Innsbruck Dr
Sunnyvale CALIFORNIA 94089 US
CEO: Erica J. Rogers
Employees: 474
Company Website: https://silkroadmed.com/
Phone: 16505669060
SILK Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 88.19 | 211.09B | ||
| ABT | ABBOTT LABORATORIES | 25.11 | 196.83B | ||
| SYK | STRYKER CORP | 32.94 | 146.17B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.81 | 145.41B | ||
| MDT | MEDTRONIC PLC | 16.78 | 112.94B | ||
| BDX | BECTON DICKINSON AND CO | 18.04 | 68.84B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.13 | 41.16B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.08 | 38.72B | ||
| RMD | RESMED INC | 28.92 | 35.20B | ||
| IDXX | IDEXX LABORATORIES INC | 38.29 | 34.33B | ||
| DXCM | DEXCOM INC | 49.64 | 32.96B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 19.55 | 24.25B |